trimetazidine has been researched along with Cardiac Output, Low in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arkharov, IV; Burbello, AT; Makhnov, AP; Shabrov, AV | 1 |
| Fedorova, TA; Il'ina, IuV; Loshchits, NV; Rybakova, MK; Sotnikova, TI | 1 |
| Abozguia, K; Clarke, K; Frenneaux, M; Lee, L | 1 |
| Alfieri, O; Calori, G; Fragasso, G; Margonato, A; Pala, M; Palloshi, A; Puccetti, P; Rossodivita, A; Silipigni, C | 1 |
| Tang, WH | 1 |
1 review(s) available for trimetazidine and Cardiac Output, Low
| Article | Year |
|---|---|
Modification of myocardial substrate use as a therapy for heart failure.
Topics: Acetanilides; Adrenergic beta-Antagonists; Animals; Cardiac Output, Low; Cardiovascular Agents; Energy Metabolism; Epoxy Compounds; Fatty Acids, Nonesterified; Glycine; Heart; Humans; Myocardium; Oxygen; Perhexiline; Piperazines; Ranolazine; Trimetazidine | 2006 |
3 trial(s) available for trimetazidine and Cardiac Output, Low
| Article | Year |
|---|---|
[Effect of trimetazidine and perindopril on myocardial function and metabolism in patients with low cardiac output during postinfarction period].
Topics: Adult; Aged; Blood Pressure; Cardiac Output, Low; Cardiovascular Agents; Drug Therapy, Combination; Electrocardiography; Energy Metabolism; Fatty Acids, Nonesterified; Glucose; Humans; Infarction; Male; Middle Aged; Myocardial Contraction; Myocardium; Perindopril; Trimetazidine | 2003 |
[Clinical and hemodynamic efficacy of selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Bisoprolol; Cardiac Output, Low; Drug Administration Schedule; Drug Therapy, Combination; Echocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Ischemia; Quality of Life; Time Factors; Treatment Outcome; Trimetazidine; Ventricular Function, Left | 2004 |
A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.
Topics: Aged; Aged, 80 and over; Cardiac Output, Low; Echocardiography; Exercise Test; Exercise Tolerance; Female; Heart; Humans; Male; Middle Aged; Myocardium; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Function, Left | 2006 |
1 other study(ies) available for trimetazidine and Cardiac Output, Low
| Article | Year |
|---|---|
Metabolic approach in heart failure: rethinking how we translate from theory to clinical practice.
Topics: Cardiac Output, Low; Clinical Trials as Topic; Drug Approval; Endpoint Determination; Evidence-Based Medicine; Humans; Trimetazidine; United States; Vasodilator Agents | 2006 |